Here's why there are such a wide variety of symptoms associated with meningitis and why not every form of meningitis is ...

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

A few years ago, the advent of technology known as CRISPR was a major breakthrough in the scientific world. Developed from a ...

Meningococcal disease is a severe, fast-progressing infection; vaccination is key for high-risk groups, preventing ...

Meningitis is a life-threatening condition caused by a bacterial or viral infection. Meningitis is an infection of the ...

GSK plc GSK announced that the U.S. Centers for Disease Control and Prevention’s (“CDC”) Advisory Committee on Immunization ...

GSK said a Centers for Disease Control and Prevention advisory board called for its drug Penmenvy to be part of the adolescent meningococcal vaccination schedule.

An INRS research team has identified a new family of enzymes that can make precise cuts in single-stranded DNA. A few years ago, the introduction of CRISPR technology marked a significant breakthrough ...

The CDC’s Advisory Committee on Immunization Practices voted April 16 to expand use of respiratory syncytial virus vaccines among high-risk adults. The updated recommendation calls for a single ...

For the first time, Professor Veyrier and his team at INRS have discovered a family of enzymes that can cut specific sequences in single-stranded DNA. These enzymes, called site-specific ...

GlaxoSmithKline recently held a high-level scientific conference in conjunction with the launch of “Bexsero,” the first ...